期刊文献+

^18F-FLTPET显像预测肿瘤放射敏感性的实验研究 被引量:1

Tumor radiosensitivity predicted by 1SF-FLT PET imaging
原文传递
导出
摘要 目的探讨^18F—FLTPET显像能否预测肿瘤放射敏感性。方法对乳腺癌MDA—MB.231细胞和脑胶质瘤LN229细胞以6MVX线照射0、8和16Gy后分别行克隆形成细胞存活率实验和^18F—FIJT细胞摄取实验,各剂量组2种细胞的数据差异行t检验,同种细胞放疗前(0Cy)与放疗后数据差异行单因素方差分析。将MDA-MB-237和LN229细胞分别接种至雌性BALB/cnu/nu裸鼠右后肢外侧皮下,待肿瘤直径长至10mm时,将2种荷瘤鼠均按0、8和16Gy分组(随机数字表法),每组20只。各组按相应剂量放疗后分别行^18F—FLTPET显像和免疫组织化学检测,计算肿瘤与肌肉的SUV比值(T/M)和TKl标记指数(uTKl),并行相关性分析。结果8Gy辐照后MDA—MB-231细胞和LN229细胞生存分数分别为(59.73±4.3)%和(93.41±3.75)%(t=-13.20,P〈0.001),16Gy时两者生存分数分别为(43.57±4.06)%和(81.77±4.42)%(t=-14.24,P〈n001)。8Gy辐照后1hMDA—MB-231细胞18F—FLT摄取降至(18.32±1.38)kBq/10’细胞[0Cy时为(128.22±8.24)kBq/10细胞,F=266.41,P〈n01],72h内保持在较低水平;LN229细胞辐照后1h摄取降至(9.87±1.30)kBq/105细胞[0Gy时为(134.88±6.59)kBq/10^5细胞,F:346.06,P〈0.01],后逐渐增加,72h时升至(127.17±9.08)kBq/10细胞(F=346.06,P〉0.05);16Gy时2种细胞摄取变化基本同8Cy组。8Gy放疗后裸鼠MDA—MB-231移植瘤18F—FlJrr摄取在第1天T/M比值下降至0.78±0.39(放疗前为2.84±0.29,F=39.78,P〈0.01),后缓慢升高,在第7天时仍低于放疗前水平(F:39.78,P〈0.01);16Cy时变化基本同8Gy组。LN229移植瘤8Gy放疗在第1天T/M比值升高至2.41±0.47(放疗前为1.58±0.29,F=34.01,P〈0.05),后逐渐降低,到第7天降至0.66±0.32(F=34.01,P〈0.05);16Gy放疗后^18F—FLT摄取值持续下降 Objective To evaluate if lSF-FLT PET imaging could be used as a new clinical method to predict tumor radiosensitivity. Methods MDA-MB-231 and LN229 ceils were irradiated with doses of 0, 8 and 16 Gy of 6 MV photon energy, then soft agar assay and cellular uptake of 18F-FLT were performed on the 2 eel1 lines. The t test and one-way analysis of variance were used for the two groups and data beforeand after irradiation. The MDA-MB-231 and LN229 tumor xenografts were prepared by injecting the tumor cells into the right limbs of female BALB/c nu/nu mice. Once tumors reached a diameter of 10 mm, the two types of mice were divided randomly into 3 groups (20 mice per group) according to the irradiation doses (0, 8 and 16 Gy). After irradiation, is F-FLT PET imaging and immunohistochemical staining were conduc- ted. Then correlations between is F-FLT SUVtumor/SUVmuscle ratio (T/M ratio) and TK1 labeling index percentages ( LITK1 ) were tested using linear correlation analysis. Results The survival fraction of MDA-MB- 231 and LN229 cells after irradiated with 8 Gy were (59.73 ± 4.3 ) % and (93.41 ± 3.75 ) %, respectively (t = - 13.20, P 〈0. 001 ). When the dose increased to 16 Gy, the survival fraction decreased to (43.57 ± g. 06) % and (81.77 ± 4.42) %, respectively (t = - 14.24, P 〈 0. 001 ). In MDA-MB-231 cells, the cel- lular uptake of ]8F-FLT after irradiation with 8 Gy declined rapidly to ( 18.32 ± 1.38 ) kBq/105 cells ( ( 128.22 ± 8.24) kBq/105 cells with the dose of 0 Gy, F = 266.41, P 〈 0.01 ), and maintained this low level till 72 h. For the LN229 cells, the cellular uptake decreased to (9.87 ± 1.30) kBq/105 cells after 8 Gy irradiation ( ( 134.88 ± 6.59) kBq/105 cells with the dose of 0 Gy, F = 346.06, P 〈 0. O1 ), then increased gradually to ( 127.17 ± 9.08) kBq/105 cells at 72 h ( F = 346.06, P 〉 0.05). The dynamic changes of lSF-FLT cellular uptake in the two cells had the same pattern after being treated with 16 Gy irr
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2013年第1期60-64,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 天津市卫生局科技基金(09KZ83)
关键词 乳腺肿瘤 神经胶质瘤 肿瘤细胞 培养的 放射疗法 体层摄影术 发射型计算机 胸苷 小鼠 Breast neoplasms Glioma Tumor cell, cultured Radiotherapy Tomography,emission-computed Thymidine Mice, nude
  • 相关文献

参考文献12

  • 1Alsner J,Hφyer M,Sφrensen SB. Interaction between potential doubling time and TP53 mutation:predicting radiotherapy outcome in squamous cell carcinoma of the head and neck[J].International Journal of Radiation Oncology,Biology,Physics,2001.519-525. 被引量:1
  • 2Everitt S,Hicks R J,Ball D. Imaging cellular proliferation during chemo-radiotherapy:a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer[J].International Journal of Radiation Oncology,Biology,Physics,2009.1098-1104. 被引量:1
  • 3Yue J,Chen L,Cabrera AR. Measuring tumor cell proliferation with 18 F-FLT PET during radiotherapy of esophageal squamous cell carcinoma:a pilot clinical study[J].Journal of Nuclear Medicine,2010.528-534. 被引量:1
  • 4Menda Y,Boles Ponto LL,Dornfeld KJ. Kinetic analysis of 3'-deoxy-3'-18 F-fluorothymidine (18F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy[J].Journal of Nuclear Medicine,2009.1028-1035. 被引量:1
  • 5Troost EG,Bussink J,Hoffmann AL. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors[J].The Journal of Nuclear Medicine,2010.866-874. 被引量:1
  • 6王卉,田嘉禾,张锦明,李天然,曲宝林,陈英茂,刘健,王珊.18F-FLT体外监测结肠癌细胞早期放射反应[J].中华核医学杂志,2010(3):147-150. 被引量:4
  • 7Potter MD,Suchowerska N,Rizvi S. Hidden stressors in the clonogenic assay used in radiobiology experiments[J].Australasian Physical and Engineering Sciences in Medicine,2011.345-350. 被引量:1
  • 8Buffa FM,Davidson SE,Hunter RD. Incorporating biologic measurements(SF2,CFE) into a tumor control probability model increases their prognostic significance:a study in cervical carcinoma treated with radiation therapy[J].International Journal of Radiation Oncology,Biology,Physics,2001.1113-1122. 被引量:1
  • 9童金龙,朱虹,陈龙邦.^18F-FLT PET显像原理及肿瘤显像研究进展[J].中华核医学杂志,2009,29(1):65-67. 被引量:5
  • 10李红梅,冯珏,张锦明,张建阳,李晓东,方凤宁,王亚平.18F—FLT及18F—FDG监测肺癌化疗后早期反应的动物实验[J].中华核医学杂志,2010(3):194-194. 被引量:6

二级参考文献49

  • 1谭业颖,田嘉禾,张锦明,姚树林,崔红英.^(18)F-FLT PET显像诊断肺单发结节及评价细胞增殖的价值[J].中华核医学杂志,2007,27(2):65-67. 被引量:20
  • 2Christman D, Crawford EJ, Friedkin M, et al. Detection of DNA synthesis in intact organisms with positron-emitting [ methyl-11 C ] thymidine. Proc Nat Acad Sci, 1972, 69: 988-992. 被引量:1
  • 3Crawford EJ, Christman D, Atkins H, et al. Scintigraphy with positron-emitting compounds llC labeled thymidine and thymidylate. Int Nucl Med Biol, 1978, 5: 61-69. 被引量:1
  • 4Gardelle O, Roelcke U, Vontobel P, et al. [ 76Br] bromodeoxyufidine PET in tumor-bearing animals. Nucl Med Biol, 2001,28 : 51- 57. 被引量:1
  • 5Lu L, Sammuelsson L, Bergstrom M, et al. Rat studies comparing 11C-FMAU,18F-FLT, and 76BrFU as proliferation makers. J Nucl Med, 2002, 43: 1688-1698. 被引量:1
  • 6Mier W, Haberkorn U, Eisenhut M. 18F-FLT: portrait of a proliferation marker. Eur J Nucl Med, 2002, 29: 165-169. 被引量:1
  • 7Shields AF, Dohmen BM, Mangner TJ, et al. Metabolism of 18FFLT in patients. J Nucl Med, 2000, 4l Suppl: 36. 被引量:1
  • 8Barthel H, Perumal M, Latigo J, et al. The uptake of 3'-deoxy- 3'-18F-fluorothymidine into LS178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Eur J Nucl Med Mol Imaging, 2005, 32: 257-263. 被引量:1
  • 9Coppock DL, Pardee AB. Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol, 1987, 7 : 2925-2932. 被引量:1
  • 10Hengstschlager M, Oliver P, Hengstshlager-Ottnad E, et al. Loss of the p16/MTS1 tumor suppressor gene causes E2F mediated deregulation of essential enzymes of the DNA precursor metabolism. DNA Cell Biol, 1996, 15: 41-51. 被引量:1

共引文献11

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部